Hypoxia-selective tumor therapy has great importance since hypoxic environment makes the tumors refractory to radiation and antineoplastic agents. The compounds with hypoxic cell sensitizing property have been evaluated in association with various therapeutic strategies and some of them are found to be operational. Sanazole (a nitrotriazole compound), a well-known hypoxic radiation sensitizer, has been attested for its hypoxiaselective activity at molecular level. In the present study, we have investigated the effect of Sanazole on transcription of major genes responsible for hypoxia-associated tumor growth, such ashif-1α, vegf and egfr, in tumor cells under in vitro and in vivo conditions. The transcriptional expressions of these genes were studied by quantitative real time PCR. The levels of nitric oxide in the tumor cells and tissues were studied by Griess test. The transcription of these geneswere up-regulated in hypoxic tumor cells while it was down regulated significantly in these cells treated with Sanazole compared to the control (normoxic) cells. The same pattern of expression was observed in tumor tissues of animals treated with Sanazole. Thus, the study revealed the effect of Sanazole in hypoxiainduced tumor growth which makes this compound useful for targeting cytotoxic drugs to hypoxic solid tumor.
INTRODUCTION
The sensitivity to therapy is mostly dependent on the genetic-epigenetic modifications and the altered microenvironment in the tumor. The reduction in the oxygen bioavailability, hypoxia, in solid tumor due to the uneven dissemination of blood vessels, made tumor more resistant to the treatments. Most of the cells respond to hypoxia by the activation of adaptive cellular responses. These responses include the transcriptional activation of factors induced by hypoxia, which encourages the expression of a series of genes that promotes aggressive tumor growth. These hypoxia-inducible factors generate resistance to chemotherapy and radiation therapy [Rockwell et al., 2009; Cosse and Michiels, 2008; Song et al., 2006; Sullivan et al., 2008] .
The hypoxia-inducible transcription factor-1 (HIF-1) is considered as an important link that coordinates the tumor progression in hypoxic condition. Structurally HIF-1 is a heterodimer of two subunits-HIF-1α and HIF-1β. In fully oxygenated cells, HIF-1α is hydroxylated at proline residues and ubiquitinated in proteasome system. Under hypoxic conditions, HIF-1α is translocated to the nucleus and it gets dimerized with HIF-1β to form active HIF-1 [Semenza, 2000; Semenza, 2001] . HIF-1 regulates the altered expression of genespromoting angiogenesis, activation of enzymes responsible for cellular energyacquiring metabolic pathways and cell proliferation [Maxwell et al., 1997] . Hypoxia in tumor therefore must be judged as a leading factor influencing tumor therapy. Hence, many approaches to evading the effects of hypoxia have been checked extensively in -81 -preclinical and clinical studies. By exploiting tumor hypoxia, directed drug targeting developed has attained a lot of importance in tumor therapy [Thambi et al., 2014] . Brown and Wilson in 2004, and Ajduković in 2016 reviewed the importance of hypoxia in tumor therapy and provided an overview about the on-going research strategies including hypoxia-selective pro-drug therapy, specific targeting to hypoxia-inducible factor-1, and hypoxia-selective gene therapy.
Several hypoxic cell sensitizers, also known as radiosensitizers, are developed to enhance the efficacy of the treatments mainly radiation therapy [Masunaga et al., 2006] and chemotherapy [Millar, 1982; Candelaria et al., 2006] in hypoxic solid tumors. In hypoxic condition, these sensitizers could overcome the treatment-resistance and enhance the therapeutic damage by mimicking the oxygen [De Ridder et al., 2008] . Sanazole (SAN), a nitrotriazole based radiosensitizer, is effective in sensitizing hypoxic cells and solid tumors [Pasupathy et al., 2001] . SAN, also known as AK2123, has a favourable level of accumulation in solid tumors with good tumor-to-blood and -muscle ratio [Das et al., 2004 ]. In the present study, the influence of SAN in the transcription of key hypoxia regulatory factor hif-1α and its target genes-vegf and egfr-was studied under both in vitro and in vivo conditions to expound the mechanism of action of SAN in hyoxic tumor cells.
MATERIALS AND METHODS

Chemicals
All chemicals and reagents were purchased from Sigma Aldrich, India. 
Studies-In vivo
To obtain animals bearing solid tumors, DLA cells (1×10 6 cells/animal) were transplanted subcutaneously in the left hind limb of female mice. When the volume of tumor reaches approximately 1cm 3 , the animals were divided into 3 groups.
Group1 was kept as control (untreated-administered with sterile distilled water); Group 2 and 3 were administered i.p. with SAN (2.5μmoles/animal). The animals in group2 and 3 were sacrificed after 1hr and 2hr of SAN administration, respectively. The blood was collected by cardiac puncture and the tissues -tumor and liver -were excised for further analyses.
Studies-In vitro
The suspension culture of cells (2×10 6 cells/ml) was prepared in Dulbecco's modified Eagle's medium (DMEM), supplemented with 12% foetal bovine serum (FBS) and
nutrients.
Experimental procedure: The cultured cells were divided into four tubes. [Normoxic condition was created by supplying 95% atmospheric air and 5% CO 2 at 37 0 C, while the hypoxic condition was created by 95% N 2 and5% CO 2 at 37 0 C.]
All tubes were incubated for 3hrs and the cells were separated by centrifugation. RNA was isolated from the cells and the transcriptional level expression of genes was studied by
Real Time PCR (qRT-PCR). The level of nitric oxide in these cells was analysed indirectly in the supernatant based on Griess reaction.
Transcriptional expression of genes
Acid guanidium thiocyanate phenol-chloroform extraction method was used to isolate RNA from cells and tumor tissues [Chomczynski and Sacchi, 1987] . The cDNA was prepared by reverse transcription with the use of random-hexamer primers as the initiating sequence. Using thecDNA qRT-PCR was performed using gene-specific primersto amplify the genes hif-1α (X95580.1), vegf (AB086118.1), and egfr (AF275367.1). The 
Nitric oxide assay
Based on the previous reports, the release of nitric oxide by SAN was measured indirectly as concentration of nitrite in the samples by Griess reaction [Grisham et al., 1996] . The samples were incubated with equal volume of Griess reagent for 10min at RT and the absorbance was measured at 543nm. Sodium nitrite (0.1-1.0nmoles) was used for the preparation of calibration curve.
Statistical analysis
The results are presented as mean±SD and were analyzed by GraphPad PRISM software version 5. Statistical significance of the results was determined using One-way analysis of variance (ANOVA) with Tukey-Kramer multiple comparisons test.
RESULTS
In vitro experiments
Transcriptional expression of hif-1α and its targeted genes
The transcriptional level expression of hif-1αis presented in 
Level of nitric oxide
The nitrotriazole compound SAN could act as NO donor. We evaluated the concentration of NO in these cells by Griess reaction in terms of nitrites and the results are presented in 
Effect of SAN in the transcription of hif-1α in tumor tissues
The Table 4 .2 presents the data on concentration of NO in tumor, liver and serum of the animals following SAN administration. The concentration of NO was found increased significantly (p<0.01) in tumor tissues after 2hrs of SAN administration. In the liver tissues of the animals, also, there was an increase (p<0.05) in the NO concentration.
SAN down regulates the transcriptional expression of vegf and egfr
However, in the serum of these animals there was no increase (p>0.05) in the concentration of NO following SAN administration compared to the control. et al., 2003 ].
In the present study, the tumor cells incubated with SAN showed increased expression of hif-1α and its target genes under normoxic condition. Sandau et al (2001) The expression of hif-1α and associated target genes -vegf and egfr -are considered as adaptive mechanisms of tumor tissues in response to hypoxia. The down regulated expression of these genes after SAN administration revealed anti-angiogenic and antiproliferative potential of SAN in enhancing therapeutic efficiency.
CONCLUSION
The hypoxic cell radiosensitizer SAN up-regulated the expression of hypoxia-inducible factors under normoxic condition, while under hypoxic condition it down-regulated their transcription. Radiation-and chemo-sensitizing property of SAN could be ascribed to the O 2 -dependent differential expression of these factors. As SAN gets accumulated in hypoxic regions of tumor specifically, this compound could be used for targeting drugs for tumor therapy.
